Role of Serotonin in Pathophysiology and Treatment of OCD.
- Author:
Chan Hyung KIM
- Publication Type:Original Article
- Keywords:
Serotonin;
Obsessive-compulsive disorder
- MeSH:
Antipsychotic Agents;
Biomarkers;
Buspirone;
Clomipramine;
Fenfluramine;
Fluoxetine;
Fluvoxamine;
Lithium;
Obsessive-Compulsive Disorder;
Paroxetine;
Personality Disorders;
Psychotic Disorders;
Serotonin Uptake Inhibitors;
Serotonin*;
Sertraline;
Tic Disorders;
Trazodone
- From:Journal of the Korean Society of Biological Psychiatry
1997;4(2):179-187
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
The clinical efficacy of serotonin reuptake inhibitors such as clomipramine in the treatment of obsessive compulsive disorder(OCD) has fueled interest in the neurobiological basis of the illness. OCD is responsive exclucively to potent serotonin reuptake clomipramine, fluoxetine, fluvoxamine, sertraline, and paroxetine and the point forms the important evidence supporting a cental role for serotonin in the pathogenesis of the disorder. Other serotonergic medications such as lithium, buspirone, trazodone, or fenfluramine may be useful as adjuvant treatments in treatment-refractory OCD and adjuvant antipsychotics are useful in tic disorder, personality disorders, and psychotic disorders. This paper reviews results of treatment studies, investigations of biological markers, and neuroendocrine challenges and implications for the role of serotonin in pathophysiology and treatment of OCD.